Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Gynecologic 1

Conditions

Colorectal Neoplasms 318Colonic Neoplasms 90Rectal Neoplasms 82Neoplasm Metastasis 42Pancreatic Neoplasms 40Carcinoma, Non-Small-Cell Lung 35Esophageal Neoplasms 25Neoplasms 21Stomach Neoplasms 20Esophageal Squamous Cell Carcinoma 14Adenocarcinoma Of Esophagus 12Squamous Cell Carcinoma of Head and Neck 11Lung Neoplasms 11Head and Neck Neoplasms 11Colorectal Cancer Metastatic 11Breast Neoplasms 9Gastrointestinal Neoplasms 7Ovarian Neoplasms 6Anus Neoplasms 6Hereditary Sensory and Autonomic Neuropathies 5Endometrial Neoplasms 5Cholangiocarcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Salivary Gland Neoplasms 4Recurrence 4Digestive System Neoplasms 4Advanced Colorectal Cancer 4Tongue Neoplasms 3

Interventions

Gemcitabine 95Cisplatin 72Capecitabine 39Oxaliplatin 38durvalumab 29Fluorouracil 27pembrolizumab 26Leucovorin 23S 1 (combination) 19Nivolumab 14Irinotecan 14lenvatinib 13Bevacizumab 13tremelimumab 10130-nm albumin-bound paclitaxel 9apatinib 8Trastuzumab 7Injections 7Immune Checkpoint Inhibitors 7Docetaxel 7Albumin-Bound Paclitaxel 7Paclitaxel 6Drug Therapy 6titanium silicide 5surufatinib 5irinotecan sucrosofate 5gemcitabine-oxaliplatin regimen 5envafolimab 5camrelizumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Cetuximab × Gastrointestinal × Clear all
NCT04956640 2026-05-29

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Eli Lilly and Company

Phase 1/2 Active not recruiting
540 enrolled
GastrointestinalGynecologicThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06024174 2025-07-22

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Bristol-Myers Squibb

Phase 1/2 Terminated
5 enrolled 9 charts
GastrointestinalThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT01267344 2016-05-04

BTC

National Health Research Institutes, Taiwan

Phase 2 Completed
122 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡